Close Menu

NEW YORK – Enzo Biochem said today that it has received New York State Department of Health approval for use of its AmpiProbe Neisseria gonorrhoeae and Chlamydia trachomatis (CT/NG) nucleic acid amplification tests with oral (pharyngeal) and rectal specimens.

The approval enables Enzo to offer the test to residents of New York state, and adds to the company's menu of molecular diagnostic tests for sexually transmitted infections (STIs).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.